BION BB Biotech AG

Media Release of March 24, 2016

BB Biotech AG: The Swiss Register of Commerce registered the resolution. The stock split will be effective starting from March 29, 2016
BB Biotech AG announces to have received confirmation that the Swiss Register of Commerce registered the resolution on March 24, 2016. The 5-for-1 stock split, approved by the General Meeting on March 17, 2016, will be effective starting from March 29, 2016. The new shares par value will be 0.20 CHF.

Investor Relations Bellevue Asset Management AG, Seestrasse 16, 8700 Küsnacht, Switzerland, Tel. +41 44 267 67 00 Dr. Silvia Schanz, ssc@bellevue.ch Maria-Grazia Iten-Alderuccio, mga@bellevue.ch Claude Mikkelsen, cmi@bellevue.ch Media Relations Bellevue Asset Management AG, Seestrasse 16, 8700 Küsnacht, Switzerland, Tel. +41 44 267 67 00 Tanja Chicherio, tch@bellevue.ch b-public AG, Pfingstweidstrasse 6, 8005 Zurich, Switzerland, Tel. +41 79 423 22 28 Thomas Egger, teg@b-public.ch www.bbbiotech.com

Company profile BB BIOTECH invests in companies in the fast growing market of biotechnology and is one of the world's largest investors in this sector. BB Biotech is listed in Switzerland, Germany and Italy. Its investments are focused on listed companies that are developing and commercializing novel medical treatments and cures. BB Biotech's investment selection process is guided by the fundamental research and analysis of physicians and molecular biologists. Its Board of Directors has many years of experience in industry and science. Disclaimer This release contains forward-looking statements and expectations as well as assessments, beliefs and assumptions. Such statements are based on the current expectations of BB Biotech, its directors and officers, and are, therefore, subject to risks and uncertainties that may change over time. As actual developments may significantly differ, BB Biotech and its directors and officers accept no responsibility in that regard. All forwardlooking statements included in this release are made only as of the date of this release and BB Biotech and its directors and officers assume no obligation to update any forward-looking statements as a result of new information, future events or other factors.

Grafico Azioni BB Biotech (BIT:BION)
Storico
Da Mag 2024 a Giu 2024

Grafico Azioni BB Biotech (BIT:BION)
Storico
Da Giu 2023 a Giu 2024